APA (7th ed.) Citation

Wang, Z., Ferrante, M., Vermeire, S., & Dreesen, E. (2025). Optimizing the switch from escalated intravenous to subcutaneous infliximab: A population pharmacokinetics–pharmacodynamics study. Journal of Crohn's & Colitis, 19(8), 1. https://doi.org/10.1093/ecco-jcc/jjaf151

Chicago Style (17th ed.) Citation

Wang, Zhigang, Marc Ferrante, Séverine Vermeire, and Erwin Dreesen. "Optimizing the Switch from Escalated Intravenous to Subcutaneous Infliximab: A Population Pharmacokinetics–pharmacodynamics Study." Journal of Crohn's & Colitis 19, no. 8 (2025): 1. https://doi.org/10.1093/ecco-jcc/jjaf151.

MLA (9th ed.) Citation

Wang, Zhigang, et al. "Optimizing the Switch from Escalated Intravenous to Subcutaneous Infliximab: A Population Pharmacokinetics–pharmacodynamics Study." Journal of Crohn's & Colitis, vol. 19, no. 8, 2025, p. 1, https://doi.org/10.1093/ecco-jcc/jjaf151.